KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Gains from Investment Securities (2016 - 2025)

Intuitive Surgical (ISRG) has 16 years of Gains from Investment Securities data on record, last reported at $19.7 million in Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 13.22% year-over-year to $19.7 million; the TTM value through Sep 2025 reached $418.5 million, up 53.69%, while the annual FY2024 figure was $270.0 million, N/A changed from the prior year.
  • Gains from Investment Securities reached $19.7 million in Q3 2025 per ISRG's latest filing, up from $16.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $370.1 million in Q1 2025 and bottomed at $6.8 million in Q2 2022.
  • Average Gains from Investment Securities over 5 years is $68.7 million, with a median of $14.2 million recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: plummeted 37.59% in 2022, then soared 78.31% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $10.4 million in 2021, then tumbled by 33.65% to $6.9 million in 2022, then soared by 114.49% to $14.8 million in 2023, then dropped by 15.54% to $12.5 million in 2024, then soared by 57.6% to $19.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $19.7 million in Q3 2025, $16.2 million in Q2 2025, and $370.1 million in Q1 2025.